AstraZeneca, a pharmaceutical company based in the U.K., made headlines in a negative light due to issues at its operations in China involving Leon Wang, the company’s president in the country.
Should one purchase AstraZeneca stock? Read More »
Avior Wealth Management LLC reduced its stake in AstraZeneca PLC by 8.5% in the third quarter, as disclosed in its latest filing with the Securities and Exchange Commission.
Avior Wealth Management LLC has sold shares of AstraZeneca PLC (NASDAQ:AZN). Read More »
AstraZeneca PLC (AZN) is meeting with management at the ESMO 2024 Conference.
AstraZeneca PLC’s Management will be attending the ESMO 2024 Conference. Read More »
The top court in Europe has made a decision against Apple, requiring the company to pay 13 billion euros ($14.4) in a recent ruling on September 10, 2024.
5 key points to consider before the stock market opens. Read More »
The top court in Europe has ruled against Apple, directing the company to pay 13 billion euros ($14.4 billion).
5 pieces of information to be aware of prior to the opening of the stock market. Read More »
Read More: https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-today-july-25-2024?utm_source=alphanewsstream.com&utm_medium=referral
Read More: https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-today-july-25-2024?utm_source=alphanewsstream.com&utm_medium=referral
Options Volatility and Projected Earnings Changes for July 25, 2024. Read More »
A healthcare company called Tempus AI (NASDAQ: TEM) that utilizes artificial intelligence (AI) to assist doctors in customizing patient care became a publicly traded company on 14 June. Established in 2015…
Could this AI growth stock, backed by Google, become the next Nvidia? Read More »
On June 14, Tempus AI (NASDAQ: TEM), a healthcare company that utilizes artificial intelligence to assist doctors in customizing patient care, went public as a promising new growth stock. Established in 2015…
A Google-supported artificial intelligence growth stock could be the next Nvidia. Read More »
Tempus AI, a healthcare company utilizing artificial intelligence to assist doctors in customizing patient care, became a publicly traded stock on June 14th. Established in 2015…
Could this AI growth stock supported by Google be the next Nvidia? Read More »
Stay updated with the latests analysis and insights fromm etfsector.com